Synthesis of isotopically labelled versions of adenosine agonist GR79236

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 43, Issue 1, 2000, Pages 11-28

  Wadsworth, Alan H ^a   Newman, John J ^a   Wipperman, Mark D ^a   Fellows, Ian ^a   Sutherland, Derek R ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Adenosine agonist; GR79236; Mass label; N nitration; Radiolabel; Recycling HPLC

Indexed keywords

NITRATION;

ADENOSINE AGONIST; ADENOSINE RECEPTOR; CARBON 14; GR79236; ISOTOPICALLY LABELED; MASS LABEL; N-NITRATION; PURINE RING; RADIOLABEL; RECYCLING HPLC;

CARBON;

6 N (2 HYDROXYCYCLOPENTYL)ADENOSINE; ADENOSINE RECEPTOR STIMULATING AGENT; CARBON 13; CARBON 14; DEUTERIUM; NITROGEN 15; RADIOPHARMACEUTICAL AGENT; TRITIUM;

ARTICLE; DRUG SYNTHESIS;

TRITIUM;

EID: 0033984021     PISSN: 03624803     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1344(200001)43:1<11::AID-JLCR286>3.0.CO;2-7     Document Type: Article

References (11)

1. Evans B. (Glaxo Group Ltd., UK) - European Patent Application EP 322242 A2 (Chem. Abs. 112:119352).
2. Gardner C.J., Twissell D.J., Coates J., and Strong P. - Eur. J. Pharmacol. 257: 117 (1994).
3. Preliminary Communication: Newman J.J., Fellows I., Wadsworth A.H., Wipperman M.D., and Sutherland D.R. - Synthesis and Applications of Isotopically Labelled Compounds 1997, Eds. Heys J.R. and Melillo D.G., John Wiley & Sons 1998, pp. 414-419.
4. Overman L.E. and Sugai S. - J. Org. Chem. 50: 4154 (1985).
5. Kelly R.C., Schletter I., Stein S.J., and Wierenga W. - J. Am. Chem. Soc. 101: 1054 (1979).
6. (a) Kinkel J.N., Gysel U., Blaser D., and Seebach D. - Helv. Chim. Acta 74: 1622 (1991);
7. (b) Additional Experimental Note: The switching valve was used to remove column eluent, when required, from a dedicated HPLC system. Eluent was otherwise pumped back to the top of the column completing a cycle, using as short a path volume as possible in order to minimise peak broadening. The HPLC system for purification of (12) used a single piston pump, which required the purpose built switching valve to be continuously connected to a small eluent reservoir to compensate system eluent volume during pump cycles. Each cycle involved 'shaving' (i.e. removing eluent) either pure product from the leading edge of the product peak or unwanted diastereoisomer from the tailing edge of the peak. The 'shaved' peak with its improved, narrowed shape was recycled. During 'shaving', the valve allowed maintenance of column pressure by allowing fresh eluent to be pumped to the top of the column from the main reservoir.
8. Brewer E. and Henion J. - J. Pharm. Sci. 87: 395 (1998).
9. Bowers G.D., Clegg C.P., Hughes S.C., Harker A.J., and Lambert S. - LC-GC 15: 48 (1997).
10. Ariza X., Bou V., and Vilarrasa J. - J. Am. Chem. Soc. 117: 3665 (1995).
11. Augustine R.L., Yaghmaie F., and Van Peppen J.F. - J. Org. Chem. 49: 1865 (1984).